Annual accounts
Total Exemption Full accounts
30/09/2026Filing deadline
Made up to 31/12/2024Due 30/09/2026
- Next accounts made up to
- 31/12/2025
- Last accounts made up to
- 31/12/2024
NOVALGEN LIMITED
Active- 11621264Copy
Copy
Registry details
Reference data exactly as held at Companies House.
Copy registry details
- Registered office
- Argyle House Level 3 Northside, Joel Street, Northwood Hills, Middlesex HA6 1NW
- Classification (SIC)
- Research and experimental development on biotechnology (72.11 - SIC 2007)
- Accounts type
- Total Exemption Full
Company activity
The 4 most recent documents filed at Companies House.
Pre-Score for UK companies is coming soon
- 14/09/2026View PDF (8 pages)
Statement of capital following an allotment of shares on 2026-09-11
- 23/07/2026View PDF (8 pages)
Statement of capital following an allotment of shares on 2026-07-13
- 22/06/2026View PDF (9 pages)
Replacement filing of SH01 - 06/05/26 Statement of Capital gbp 214.171820
- 17/06/2026View PDF (8 pages)
Statement of capital following an allotment of shares on 2026-05-20
Coming soon
What Pre-Score will tell you
- Whether the filed accounts are strengthening or weakening year on year.
- Whether this company files on time, and how often its record changes.
- How its officers and controlling parties connect to other UK companies.
Accounts and confirmation statement
The two filings Companies House requires every year, and where each one stands against its deadline today.
Due in 5 days
Confirmation statement
Confirms the registry record is up to date
- Next statement date
- 13/10/2026
- Last statement dated
- 31/12/2024
Financial performance
The latest figures NOVALGEN LIMITED filed. Okredo holds filed accounts data for 2021–2025; the year-by-year record is on the financials page.
Net Assets
£3.53M2025
-8.64%vs 20242024: £3.86M
Total Assets
£4.95M2025
3.36%vs 20242024: £4.79M
Cash in Bank
£1.37M2025
100.49%vs 20242024: £683.20K
Total Liabilities
£1.37M2025
73.93%vs 20242024: £788.34K
Employees
02025
0vs 20242024: 0
Of the 4 measures with an earlier filing to compare against, 3 rose and 1 fell. Cash in bank moved furthest, up 100.49% on 2024. See the full financial analysis for NOVALGEN LIMITED.
The full financial record
Four ways through NOVALGEN LIMITED's filed accounts — the year-by-year numbers, the compound rates and the ratios behind them.
Net Assets · -25.5% a year (CAGR)Three-year trend, 2023–2025Every measure end to end across 2023, 2024 and 2025, with the compound rate behind each one.See what moved5 chartsCharts by indicator5 filed indicators plotted year by year, 2021–2025.Plot the figuresNothing estimatedRatios from the filed figures4 ratios computed from this company's own reported amounts, each shown against the year it was derived from.Check the ratios5 × 5 yearsEvery figure by yearAll 5 measures Okredo tracks across 5 reported years, exactly as filed.Open the table
Employees
Headcount as reported to Companies House for 2021–2025.
| Year | Employees | Change |
|---|---|---|
| 2025 | 0 | 0 |
| 2024 | 0 | -17 |
| 2023 | 17 | -2 |
| 2022 | 19 | -5 |
| 2021 | 24 | – |
Reported employee count decreased from 24 in 2021 to 0 in 2025. See how headcount moved alongside the reported financials.
Credit report
It is a professional assessment of the company 's performance, revealing company's potential and risks, showing it's past experiences and revealing future prospects.
- Company potential
- Risk indicators
- Past performance
- Future prospects
Officers
13Directors, secretaries and other appointed officers, with the period each has served.
| Person | Role | Period | Connected companies |
|---|---|---|---|
| Director | 07/01/2019–Present | 158 | |
| Director | 24/03/2023–Present | 0 | |
| Director | 14/10/2018–31/03/2022 | 7 | |
| Director | 06/01/2020–Present | 11 | |
| Director | 07/01/2019–06/01/2020 | 11 | |
| Director | 07/01/2019–Present | 25 | |
| Director | 02/12/2020–19/05/2023 | 4 | |
| Director | 07/01/2019–15/02/2023 | 4 | |
| Director | 07/01/2019–05/12/2022 | 1 | |
| Director | 03/01/2023–Present | 3 | |
| Corporate Director | 15/02/2023–Present | 10 | |
| Director | 09/12/2022–Present | 0 | |
| Director | 14/05/2026–Present | 0 |
Persons with significant control
3Individuals or entities with significant control over the company, as declared to Companies House.
| Person | Period | Connected companies |
|---|---|---|
| 31/05/2019–Present | 0 | |
| 14/10/2018–20/03/2020 | 11 | |
| 22/01/2026–Present | 0 |
Filing history and recent activity
Every document on the Companies House record, newest first.
- Filings on record
- 77 Since 01/11/2021
- Last 12 months
- 32 +13 vs the year before
- Most recent filing
- 14/09/2026 less than a month ago
What changed in the last year
- Share capital (27)Latest 14/09/2026
- Accounts filedLatest 13/03/2026
- Confirmation statement (2)Latest 07/03/2026
- Officer changes (2)Latest 12/02/2026
Filing timeline
- 14/09/2026View PDF (8 pages)
Statement of capital following an allotment of shares on 2026-09-11
- 23/07/2026View PDF (8 pages)
Statement of capital following an allotment of shares on 2026-07-13
- 22/06/2026View PDF (9 pages)
Replacement filing of SH01 - 06/05/26 Statement of Capital gbp 214.171820
- 17/06/2026View PDF (8 pages)
Statement of capital following an allotment of shares on 2026-05-20
- 17/06/2026View PDF (8 pages)
Statement of capital following an allotment of shares on 2026-05-21
- 19/05/2026View PDF (9 pages)
Statement of capital following an allotment of shares on 2026-05-06
- 13/04/2026View PDF (8 pages)
Statement of capital following an allotment of shares on 2026-03-20
- 13/04/2026View PDF (8 pages)
Statement of capital following an allotment of shares on 2026-03-09
- 13/04/2026View PDF (8 pages)
Statement of capital following an allotment of shares on 2026-03-27
- 13/03/2026View PDF (12 pages)
Total exemption full accounts made up to 2025-12-31
- 07/03/2026View PDF (12 pages)
Second filing of Confirmation Statement dated 2025-10-13
- 03/03/2026View PDF (8 pages)
Statement of capital following an allotment of shares on 2026-02-09
Showing 12 of 77 filings
See when the next accounts and confirmation statement are due
Similar companies
69 UK companies are similar to NOVALGEN LIMITED, sharing the same company status (Active), the same industry sector and activity group (Research and experimental development on biotechnology) and a comparable number of employees. The 5 closest matches are shown below to help you compare competitors and industry peers.
PEPTCELL LIMITED
Active4th Floor, Silverstream House,, 45 Fitzroy Street, London W1T 6EB
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 04983543
- Incorporated
- 03/12/2003
- Employees
- 0
I-BODI LTD
ActiveUnit 8 Swan Business Centre, Osier Way, Buckingham, Buckinghamshire MK18 1TB
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 05572182
- Incorporated
- 23/09/2005
- Employees
- 0
LEVITY CROPSCIENCE LIMITED
ActiveCrowhall Farm Newsham Hall Lane, Woodplumpton, Preston PR4 0AS
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 07125879
- Incorporated
- 14/01/2010
- Employees
- 0
LIG NANOWISE LIMITED
ActiveUnit 18, Williams House Lloyd Street North, Manchester Science Park, Manchester M15 6SE
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 08835324
- Incorporated
- 07/01/2014
- Employees
- 0
LIG TECHNOLOGIES LIMITED
ActiveApartment 13 Queens College Chambers, 38 Paradise Street, Birmingham B1 2AF
- Activity
- Other research and experimental development on natural sciences and engineering
- Company no.
- 08827993
- Incorporated
- 31/12/2013
- Employees
- 0
About NOVALGEN LIMITED
A short description of the company, written from its Companies House record.
NOVALGEN LIMITED is a private limited company registered in the United Kingdom, based in Argyle House Level 3 Northside, Joel Street, Northwood Hills, Middlesex HA6 1NW. Companies House classifies its business as Research and experimental development on biotechnology. It has been on the register for 7 years 11 months.
The register currently records it as active. Its 2025 accounts report net assets of £3.53M and 0 employees.
NOVALGEN LIMITED: frequently asked questions
Answered from this company's own registry record and filed figures.
What does NOVALGEN LIMITED do?
Companies House records NOVALGEN LIMITED under one registered business activity: Research and experimental development on biotechnology (72.11 - SIC 2007).
Is NOVALGEN LIMITED still active?
NOVALGEN LIMITED is recorded as active on the Companies House register, and has been on it since 14/10/2018.
What are NOVALGEN LIMITED's latest reported financials?
The most recent accounts Okredo holds cover 2025 and report net assets of £3.53M, total assets of £4.95M, cash in bank of £1.37M and total liabilities of £1.37M.
When did NOVALGEN LIMITED last file with Companies House?
The most recent document on the record is dated 14/09/2026: Statement of capital following an allotment of shares on 2026-09-11, less than a month ago.
When are NOVALGEN LIMITED's next filings due?
On the current registry record, accounts are due by 30/09/2026.
Who runs NOVALGEN LIMITED?
Companies House lists 13 officers (8 currently in post) and 3 people with significant control (2 current).